Clicky

Shanghai Haohai Biological Tech Co(688366)

Description: Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, the United States, the United Kingdom, and internationally. It offers ophthalmology products comprising intraocular lens, ophthalmic viscoelastic devices, orthokeratology and phakic refractive lenses, eye drops, injectors, scalpels, etc.; orthopedics products, such as sodium hyaluronate injection and medical chitosan; wound repair products, including recombinant human epidermal growth factor for the treatment of burn wound, residual wound, donor site posttraumatic wound, and fresh or old wound of chronic ulcer; anti-adhesion materials comprising medical sodium hyaluronate gel and medical chitosan; and hemostatic materials, such as collagen sponge and porcine fibrin sealants. The company also provides medical aesthetics products comprising Matrifill, a first-generation HA dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; and radio frequency devices and laser equipment. In addition, it is involved in research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; and investment and trading business. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.


Keywords: Laser Pharmaceutical Products Chemical Compounds Consultation Services Technology Transfer Hyaluronic Acid Glycosaminoglycans Laser Equipment Antihemorrhagic Injectable Filler Sodium Hyaluronate Chitosan Ophthalmology Products Medical Aesthetics Products Orthopedics Products Chronic Ulcer Donor Site Ophthalmic Viscoelastic Devices Radio Frequency Devices Wound Repair Products

Home Page: www.3healthcare.com

WenGuang Plaza
Shanghai,
China
Phone: 86 21 5229 3555


Officers

Name Title
Dr. Yongtai Hou Exec. Chairman
Dr. Jianying Wu GM & Exec. Director
Mr. Minjie Tang CFO & Exec. Director
Ms. Yiyi Chen Exec. Director
Ms. Caixia Ren Deputy Gen. Mang.
Mr. Wenbin Wang Deputy Gen. Mang.
Dr. Jundong Zhang Deputy Gen. Mang.
Mr. Ming King Chiu FCIS, FCS Joint Company Sec.
Ms. Min Tian Joint Company Sec.

Exchange: SHG

Country: CN : China

Currency: Renminbi (¥)

Forward PE: 35.3357
Trailing PE: 93.7273
Price-to-Book MRQ: 2.6625
Price-to-Sales TTM: 6.3888
IPO Date:
Fiscal Year End: December
Full Time Employees: 1892
Back to stocks